|
HS Code |
227581 |
| Iupac Name | 3-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4-hydroxy-2H-chromen-2-one |
| Molecular Formula | C19H16O3 |
| Molecular Weight | 292.33 g/mol |
| Cas Number | 23569-56-0 |
| Appearance | White to off-white crystalline powder |
| Melting Point | 163-165 °C |
| Solubility | Sparingly soluble in water, soluble in organic solvents |
| Synonyms | Tetrindole-4-hydroxycoumarin, 3-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4-hydroxycoumarin |
| Chemical Class | 4-Hydroxycoumarin derivative |
| Structure Type | Polycyclic aromatic with coumarin core |
| Logp | Estimated 4.2 |
| Storage Conditions | Store at room temperature, protect from light |
| Hazard Statements | May be harmful if swallowed or inhaled |
As an accredited 3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 25 grams of 3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin, labeled with product details and safety information. |
| Shipping | The chemical **3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin** is shipped in tightly sealed, inert containers to prevent contamination or degradation. It is packaged according to regulations for laboratory chemicals, with proper labeling and documentation. Shipping is conducted under temperature-controlled conditions if required, and includes all relevant safety and hazard information. |
| Storage | Store 3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin in a tightly sealed container, protected from light and moisture, in a cool, dry, and well-ventilated area. Keep away from incompatible substances such as strong oxidizers. The storage area should be clearly labeled and restricted to authorized personnel. Handle using appropriate protective equipment to prevent inhalation and skin contact. |
Applications of 3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin in Industrial ManufacturingAs a direct manufacturer of 3-(1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin, we have established supply partnerships with industrial formulators and downstream producers requiring advanced coumarin derivatives for regulated end-uses. The following application sectors and integration details reflect real industrial adoption, supported by current quality system and regulatory practice. 1. Anticoagulant Active Pharma Ingredient (API) ProductionPharmaceutical companies utilize this coumarin derivative primarily for synthesizing anticoagulant APIs, leveraging its functional motif which confers vitamin K antagonism central to finished drug activity. The integration process involves precise stoichiometric addition in multi-step active pharmaceutical ingredient synthesis, forming the backbone of oral anticoagulant drugs for chronic cardiovascular management. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Rodenticide Technical FormulationsSpecialty chemicals producers employ 3-(1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin as a key technical agent in second-generation anti-coagulant rodenticide concentrates. This application requires careful alignment with established safety controls and environmental regulations, since persistent residues must remain within regulated toxicological limits in grain bait and pellet formats. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Livestock Premix & Veterinary FormulationsAnimal health manufacturers depend on the precision blending of coumarin-type derivatives into veterinary premixes for controlled anticoagulation therapies in livestock. This application focuses on traceability and controlled dosage protocols to prevent toxicity, utilizing regulated inclusion rates and batch record requirements for medicated feed additive registration. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Research Reagents for Blood Coagulation StudiesResearch and diagnostic reagent manufacturers incorporate this compound into validated in-vitro laboratory kits for anticoagulant screening and blood coagulation pathway studies. This scenario requires analytical traceability and reproducibility at controlled concentrations, supporting accredited laboratory testing in clinical, university, and industrial R&D applications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In our years producing 3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin, we have learned that precision at every stage—synthesis, purification, tailoring crystal morphology, even packaging—strengthens quality. We follow a defined process from raw material screening through final batch QC, reviewing every output. The naphthyl group’s tetrahydro configuration creates a compound quite distinct from traditional coumarin derivatives. Our team treats each step with respect for both the molecule’s reactive features and the high performance standards expected by formulators.
Producing this molecule at large scale introduces constant hurdles. Each batch, no matter the volume, must be tested beyond generic benchmarks. The hydroxycoumarin backbone can pick up minute impurities that alter solubility or bioreactivity if left unchecked. So, we keep instruments tuned and demand standards above industry “minimum pass” marks. From HPLC purity readings to drying curves and glass transition observations, long-term experience shapes how we assure repeatability. We encounter requests for various particle size profiles and will adjust synthesis or milling steps to get exact specifications. This results from listening to feedback and understanding downstream processing, not just relying on supplier recommendations.
The way tetrahydronaphthyl groups interact with hydroxycoumarin rings influences this compound’s physical properties, stability under light and air, and compatibility with a broad set of co-ingredients. This unique structure drives its value in anticoagulant agents, biochemical research, and intermediate synthesis for further modification. We have run stress tests on exposure to various excipients, solvents, and pH conditions. Unlike straight-chain or unmodified coumarins, our product resists oxidative breakdown much more effectively.
Over the years, we responded to direct customer feedback, not only providing a standard grade but also developing higher purity lines and alternative morphology options. Some service sectors favor a fine powder for suspension formulations, while others want coarse crystals for direct tablet pressing. Our technical team reviews every order specification, adjusting process parameters such as crystallization temperature or antisolvent selection. We never shortcut purification through speculative tweaks. Instead, we continuously experiment with process adjustments to see what results bring the highest consistency and batch-to-batch reproducibility over time.
Many coumarin derivatives offer structural elegance but lack the stability required for high-precision use. Our 3-(1,2,3,4-Tetrahydro-1-Naphthyl) modification increases molecular rigidity and changes physicochemical properties in a way basic 4-hydroxycoumarins do not. In our process, we’ve seen less tendency toward degradation, even under repeated handling or exposure to UV. Labs working with standard 4-hydroxycoumarin often report short shelf life or unpredictable solubility. We decided long ago to monitor every metric around these pain points—so particle size distribution, stability data, and impurity profiles remain front and center. This focus has led to a form which researchers and formulating chemists handle with less loss and fewer compatibility issues downstream.
Any manufacturer can print a product specification from a textbook, but our best insights come from the shop floor. It starts with vetted supply chains for feedstock naphthalenes and solvents, followed by skilled reaction monitoring. Even minor inconsistencies in temperature control shift product ratios and have downstream effects. One heated vessel running two degrees higher can set us back days in recrystallization. Our operators double-check every valve setting and sample frequently to stay ahead of drift. Post-reaction, we put as much energy into purification—using column chromatography or multi-stage washing—as we do into the original synthesis. R&D and production teams meet every month to share results and catch blind spots.
Scientific end users expect full documentation, and for good reason. A physiochemical test suite covers melting point, loss on drying, heavy metal content, and specific impurity monitoring. The tetrahydro-1-naphthyl group complicates routine QC, since common assays can underreport some trace byproducts. We developed in-house reference standards and custom calibration curves using recognized international frameworks, such as ICH Q6A. This isn’t about ticking regulatory checklists— it’s about creating certainty for partners down the supply chain who depend on our transparency.
Researchers and formulators frequently face the problem of poor compound dispersibility or aggregation in complex mixtures. During collaborative projects, we learned the importance of tailoring drying methods to suit end-use—vacuum tray drying for one customer, spray drying for another. When a formulation partner struggled with unexpected phase separation, our technical team ran controlled stability trials and helped adjust both our particle size and their mixing protocol. We saw that cutting corners—even shaving a few hours off drying—could change dispersibility, which in turn could affect activity in bioassays. Applying firsthand knowledge of how our molecules behave in real-world settings has led to product versions that go beyond a typical catalog entry.
Commoditized chemical distributors often promise endless stock. From the manufacturer’s desk, raw material volatility and shipping disruptions never disappear. A few years back, a shipping hold-up forced us to recalibrate not just logistics but also inventory management. We inform clients, especially those running tight research timelines, about worst-case lead times. This transparency helps them plan, and it pushes us to maintain higher inventory of key intermediates. We learned to diversify supply chains and keep direct relationships with key upstream vendors. These practices, while increasing operating costs, provide more reliable access to quality product for those who refuse to accept mediocrity.
Real insight comes from those who actually formulate, dose, or modify this compound. We support partners who feed data back to us on performance. When a team saw a drift in assay response related to ambient humidity, our own QC chemists replicated the conditions and isolated the variable. These details inform tweaks that make each new batch more stable season after season. Direct relationships with downstream users amplify our understanding of nuanced technical challenges and give us a foundation for more robust quality improvement.
The global chemical landscape faces tightening regulatory oversight, especially for compounds used as pharmaceutical intermediates or in specialty crop protection. We engage with evolving standards—not just for the sake of compliance, but because unchecked impurities or handling risks sabotage years of R&D progress. Recent EU regulations required us to re-examine process solvents and requalify residual profiles. Rather than waiting for external audits to prompt change, our compliance desk works ahead of the regulatory curve. We produce regular reviews of REACH and US EPA updates and invest in in-house training so every technician knows what’s at stake. It’s not the least costly approach, but it’s the one that lets us keep customer trust long term.
Waste minimization takes center stage. Not just because regulators care—although they do—but because solvent recovery and effluent pre-treatment safeguard future operations from unnecessary shutdowns. We engineered multi-stage solvent recovery loops so acetonitrile and THF recycling decreased new purchase volumes. Our water treatment plant removes chlorinated organic traces well below national thresholds. These investments don’t attract instant praise, but they let us operate with a cleaner conscience. It’s not always an easy sell internally, but the long-term competitive advantage grows as environmental reporting requirements become stricter worldwide.
Older equipment often brings hidden variability to final product quality, whether through cross-contamination, worn seals, or reaction vessel scaling. Over the past several years, we allocated funds not only for new reactors and filtrations systems but also for digital monitoring and feedback control systems. This data-centric production gives us tighter control over reaction endpoints and batch traceability. When upgrades slow output for a week, we prioritize validation of new systems in partnership with production, not just IT. Over time, this reduces operator error and increases confidence in every lot shipped.
Chemistry remains a field where rote training only goes so far. Our best results came from investing in flexible training that exposes junior staff to both synthesis and QC. We developed a mentoring system where production leads teach hands-on troubleshooting—from glassware assembly to real-time process adjustments based on sample readings. This helps bridge the gap between academic chemical training and the realities of industrial-scale synthesis, reducing onboarding time and increasing team-wide expertise.
Market demand for high-purity specialty molecules appears cyclical, but firms treating these as commodities tend to ignore true cost drivers—deviation management, repeat analysis, regulatory reporting, and waste reduction. Our price advantages come less from chasing the cheapest feedstocks and more from optimizing every step, reducing rework, and ensuring long-run stability. Clients who compare purely on price often experience run-ins with inconsistent supply or hidden impurity profiles. Transparent communication about what goes into each order changes the value equation and builds long-term confidence.
Over years of production, we accumulated detailed dataset on yields, impurity patterns, equipment performance, and customer feedback. We conduct frequent trend analyses, using both operator notes and digital logs. If a seemingly minor shift in precipitation temperature links to a higher incidence of filtration problems, we trace it back and update our standard operating procedures. Our best process changes came from connecting data across several disciplines—synthesis, purification, and even last-mile packaging.
Innovation doesn’t come from siloed R&D. We frequently open our labs to pilot studies with partner organizations, allowing them to run test batches in our equipment. This direct collaboration accelerates feedback and highlights process nuances that wouldn’t surface in off-site trials. By working side-by-side, our chemists gain new perspectives into ultimate application requirements, leading to iterations that better align with both the scientific and operational needs of end users.
As specialty chemicals gain value, reports of counterfeit or substandard versions rise. We respond with multi-level product tagging, batch-linked certifications and supplier audits. A clear paper trail, from kilogram drums to final application, underpins trust in the material’s authenticity. Where possible, we share data with key partners to jointly monitor supply chain integrity and identify at-risk points before issues arise. While these measures involve new technology and documentation costs, the assurance they grant to researchers and formulators far outweighs up-front investment.
Supplying high-value chemical intermediates across continents involves tight customs compliance, multilingual documentation and familiarity with local quality requirements. Our technical support group works across time zones, providing application-specific guidance and troubleshooting. These hands-on partnerships have helped bridge knowledge gaps as regulations and market trends shift regionally. As researchers in one country push the boundaries of anticoagulant analogs while another group seeks process-friendly intermediates, we tune our product and service model to remain relevant.
Over years, product specifications changed, regulatory expectations shifted, but the fundamentals stayed the same: control every variable—human or technical—and stay close to users’ real-world needs. We have seen new users train on our compound for the first time and seasoned formulators modify old methods based on a new batch’s subtle behavior. The signals are often subtle—slower filtration, a change in color, an unusual result in a stability assay. By focusing on technical accuracy, user collaboration and real-world feedback, we continue to build a product line that sets a higher standard for both performance and reliability in chemical manufacturing.
Serving research, pharmaceutical, and technical markets with this compound shapes our daily routines, decisions, and investments. Unlike short-lived ordering relationships, we’ve learned to grow through candid conversations about both failures and successes. Years of incremental improvements, from pilot batch to scaled production, force us to ask not only “How pure?” but “How useful in the field?” We focus on making every shipment a tool researchers can count on, not just a line item on an invoice. It’s these principles—rooted in experience, honest problem-solving, and attention to detail—that let a specialty chemical like 3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin deliver meaningful results in the lab and beyond.